 anticardiolipin antibodi polymyalgia rheumatica-gi cell arter associ sever vascular complic purpos group patient polymyalgia rheumatica pmr biopsy-proven giant cell arter gca order preval anticardiolipin antibodi acl disord associ vascular complic patient method studi patient pmr gca determin igg igm acl enzyme-link immunosorb assay patient age- sex-match healthi control subject von willebrand factor vwf antigen c-reactiv protein erythrocyt sediment rate result twenty-four patient eleven posit igg igm wherea posit group patient pmr patient gca antibodi control group patient posit acl find differ find patient gca isotyp acl patient gca patient sever vascular complic level vwf antigen patient gca patient pmr titer vascular complic erythrocyt sediment rate c-reactiv protein compar group conclus studi acl preval patient gca antibodi sever vascular damag import role pathogenesi vasculopathi diseas